publication date: Dec. 21, 2010
In this issue:
As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray;
Texas Oncology Designated Aranesp As Preferred Treatment;
After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk;
Foundation Gives $1 Million To UPCI For Genetics Chair;
Download (PDF 376KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.